top of page

Home
About
All News
Contact
Advertise
Members
More

Use tab to navigate through the menu items.

News & Latest Updates

All Posts
Guidelines
Clinical Trials
Patient Stories & PEL
Case Reports
New Approvals
Spotlight

ASCOT-LLA Study: Atorvastatin vs placebo in primary prevention of CHD

ASCOT-LLA Study: Atorvastatin vs placebo in primary prevention of CHD

ASCOT-LLA Study: Atorvastatin vs placebo in primary prevention of CHD

Sever PS et al, conducted the ASCOT-LLA study to assess the efficacy of Atorvastatin 10 mg in the prevention of coronary and stroke...

Ms. Roma Joglekar

Sep 92 min read

Atorvastatin vs placebo in the primary prevention of CHD: CARDS Study

Atorvastatin vs placebo in the primary prevention of CHD: CARDS Study

Atorvastatin vs placebo in the primary prevention of CHD: CARDS Study

Colhoun HM, et al. conducted the CARDS ( The Collaborative Atorvastatin Diabetes Study) study, which compared the efficacy of...

Ms. Roma Joglekar

Sep 91 min read

Subscribe to Our Newsletter

Join our mailing list

Email*

I want to subscribe to your mailing list.

Home
About
All News
Contact
Advertise
Members

© 2025 RxNews. All Right Reserved.

bottom of page